tiprankstipranks
Antibe Therapeutics (ATBPF)
OTHER OTC:ATBPF
US Market

Antibe Therapeutics (ATBPF) Stock Forecast & Price Target

108 Followers
See the Price Targets and Ratings of:

ATBPF Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Antibe
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ATBPF Stock 12 Month Forecast

There Are No Analyst Ratings for ATBPF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ATBPF Financial Forecast

ATBPF Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

ATBPF Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Analyst Performance
Any
Any
Analyst Rating
Any
Any
Upside / Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group
Hold
Downgraded
03/05/24
Antibe Therapeutics downgraded to Hold from Buy at MaximAntibe Therapeutics downgraded to Hold from Buy at Maxim
Echelon Wealth Partners
Buy
Reiterated
03/04/24
Antibe Therapeutics placed Under Review at EchelonAntibe announced today an unexpected US$24M ($32.6M) arbitration decision from the Singapore International Arbitration Centre in favour of Nuance Pharma for the recoupinof the US$20M upfront payment (and an additional US$4M in interest and legal costs) paid to Antibe in 2021 by Nuance for the marketing rights of otenaproxesul in China, the analyst noted.
Paradigm
$1.5
Buy
$1.50
(595.73% Upside)
Reiterated
02/28/24
Antibe Therapeutics has more upside still, Paradigm saysBy Nick Waddell Published on February 28, 2024 Last Updated on February 28, 2024 Filed under: All posts , Analysts , Life Sciences Stock: ateAntibe Therapeutics has more upside still, Paradigm says

Best Analysts Covering Antibe Therapeutics

Which Analyst Should I Follow If I Want to Buy ATBPF and Sell After:
1 Month
xxx
Success Rate
4/15 ratings generated profit
27%
Average Return
-7.89%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 26.67% of your transactions generating a profit, with an average return of -7.89% per trade.
3 Months
xxx
Success Rate
5/15 ratings generated profit
33%
Average Return
-14.81%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -14.81% per trade.
1 Year
Stefan QuennevilleEchelon Wealth Partners
Success Rate
2/15 ratings generated profit
13%
Average Return
-38.15%
reiterated a buy rating 5 months ago
Copying Stefan Quenneville's trades and holding each position for 1 Year would result in 13.33% of your transactions generating a profit, with an average return of -38.15% per trade.
2 Years
xxx
Success Rate
1/15 ratings generated profit
7%
Average Return
-54.63%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 6.67% of your transactions generating a profit, with an average return of -54.63% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ATBPF Analyst Recommendation Trends

Rating
Jun 23
Aug 23
Nov 23
Feb 24
Mar 24
Strong Buy
3
5
6
7
5
Buy
0
0
0
0
1
Hold
1
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
6
7
7
In the current month, ATBPF has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ATBPF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

ATBPF Stock Forecast FAQ

What is ATBPF’s average 12-month price target, according to analysts?
Currently, no data Available
What is ATBPF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ATBPF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ATBPF a Buy, Sell or Hold?
      Currently, no data Available
      What is Antibe Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Antibe Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ATBPF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis